← 返回

通过尿石素 A 诱导的线粒体自噬扩增具有优越抗肿瘤免疫力的 T 记忆干细胞

英文原题:Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.

查看英文原题

Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy.

PubMed 2022/10/19(内容时间) Immunity Q1 · IF 30.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

T记忆干细胞(T SCM)表现出增强的自我更新和延长存活能力,从而防止T细胞耗竭并促进有效的抗肿瘤T细胞反应。T SCM细胞可通过尿石素A(UA)扩增,UA由共生肠道微生物群从富含鞣花酸的食物中产生,并已知可改善线粒体健康。对荷瘤小鼠口服UA可赋予强烈的抗肿瘤CD8+ T细胞免疫,而体外UA预处理的T细胞在过继性细胞转移后表现出改善的抗肿瘤功能。UA诱导的T SCM形成依赖于Pink1介导的线粒体自噬触发线粒体磷酸酶Pgam5的胞质释放。胞质Pgam5使β-catenin去磷酸化,从而驱动Wnt信号传导和代偿性线粒体生物发生。总之,我们揭示了一条将线粒体自噬与T SCM形成联系起来的关键信号通路,并表明耐受性良好的代谢化合物UA代表了一种改善免疫治疗的有吸引力的选择。

展开英文摘要原文

T memory stem cells (T SCM ) display increased self-renewal and prolonged survival capabilities, thus preventing T cell exhaustion and promoting effective anti-tumor T cell responses. T SCM cells can be expanded by Urolithin A (UA), which is produced by the commensal gut microbiome from foods rich in ellagitannins and is known to improve mitochondrial health. Oral UA administration to tumor-bearing mice conferred strong anti-tumor CD8 + T cell immunity, whereas ex vivo UA pre-treated T cells displayed improved anti-tumor function upon adoptive cell transfer.

UA-induced T SCM formation depended on Pink1-mediated mitophagy triggering cytosolic release of the mitochondrial phosphatase Pgam5. Cytosolic Pgam5 dephosphorylated β-catenin, which drove Wnt signaling and compensatory mitochondrial biogenesis. Collectively, we unravel a critical signaling pathway linking mitophagy to T SCM formation and suggest that the well-tolerated metabolic compound UA represents an attractive option to improve immune therapy.

论文信息

作者
Denk D、Petrocelli V、Conche C、Drachsler M、Ziegler PK、Braun A、Kress A、Nicolas AM
第一作者单位
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; Department of Medicine 1, Goethe-University Hospital Frankfurt, Frankfurt/Main, Germany.Germany
通讯作者单位
Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, 60596 Frankfurt/Main, Germany; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany; Frankfurt Cancer Institute, Goethe University Frankfurt, 60596 Frankfurt/Main, Germany. Electronic address: greten@gsh.uni-frankfurt.de.Germany
文献类型
非美国政府资助研究
期刊
Immunity2022 Nov 8
原文标识
PubMed 36351375 · DOI 10.1016/j.immuni.2022.09.014